(2R)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidinecarboxylic acid phenylmethyl ester

1-Pyrrolidinecarboxylic acid, 2-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)-, phenylmethyl ester, (2S)-

pharmaceutical intermediate

Acalabrutinib Impurity 10

Acalabrutinib impurity reference standard

4-[5-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]-10-methyl-12-oxo-4,6,9,13-tetrazatricyclo[7.4.0.02,6]trideca-1(13),2,4,7,10-pentaen-3-yl]-N-pyridin-2-ylbenzamide

Acalabrutinib impurity reference standard

5,6-Dihydroabiraterone

Impurity standard for abiraterone synthesis

3-Fluoro-4-hydroxymethylbenzonitrile

pharmaceutical intermediate

(S)-Oxetan-2-ylmethyl 4-methylbenzenesulfonate

Pharmaceutical intermediate

Betti base hydrochloride

chiral building block for synthesis

Benzyl 2-(8-amino-1-bromo-imidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate

Pharmaceutical intermediate for impurities